Skip to Main Content

Patient-centred Hereditary Ovarian Cancer Prevention and Survivorship Care in Canada

Precision medicine for patients with co-existent ovarian and endometrial cancer: the COMPARE trial

Clonal hematopoiesis as a biomarker of poor prognosis in high-grade serous ovarian cancer

Prevalence and Experience of Traumatic Stress in Patients with Newly Diagnosed and Recurrent Advanced Ovarian Cancer

Enabling a Phase I Clinical Trial of a Novel CAR-T Cell Therapy for Ovarian Cancer

Improving access to opportunistic salpingectomy in Canada: a collaboration with the Ovarian Cancer Observatory

Development and characterization of humanized patient-derived xenograft models for ovarian cancer

Investigating the proteome and secretome of ovarian cancer to inform early detection and treatment

Uncovering targetable interactions of ovarian cancer cells

Uncovering novel metabolic regulators of T cell function